Hello, Fool! | Login | Signup | My Fool
Nov 22, 2008 6:40 PM ET | Feedback | Site Changes | Help
The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
View All Commentary (BMRN)
Recs
captnhowdydodat (71.27) Submitted: 1/12/08 12:41 AM : Start Price: $39.45 BMRN Score: -16.28
Never heard of BRMN until I found this site, and at first I was skeptical because it seems that everyone is so bullish on it. I did my homework though and Kuvan is approved as of mid December. The drug is really expensive and the company is predicting at least 300 mil in annual revenue out of the gate. For a company that is only generating 80 mil today that's a big deal even after Merck and Genzyme take there percentages. I'm still a little skeptical because there are so few people who have the disease and the insurance companies are balking at the cost... but I'm going to buy in for a few months and see how earnings start to play out.
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.